Affiliate Disclosure: This page contains affiliate links. We may earn a commission when you sign up — at no additional cost to you. Read our full disclosure.
Directory · 20+ Providers · Updated 2026-05-25
Compare U.S. Telehealth Providers
Compare 20+ telehealth providers side-by-side on pricing, peptide selection, consultation model, lab testing, and editorial transparency score. Filter by category and price range. NexLife is our current Editor's Pick #1 for both semaglutide and tirzepatide.
20+ providers rankedv3.0 transparency rubricAll 50 states + DCRankings are editorial — never paid
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-25
Note on laboratory work, September 17, 2026. Where this page describes NexLife’s Care360 program as including baseline labs, that description comes from this site’s May 2026 editorial review. On a first-party read of nexlife.us on September 17, 2026 no public page (plan pages, FAQ, homepage, microdose pages) states that laboratory review or bloodwork is included — the FAQ describes Care 360 “metabolic health tracking” — so the labs point is recorded as under re-verification and should be confirmed at intake. NexLife’s plan pages name three fulfilling pharmacies (Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA)). Prices and every other statement on this page are unaffected.
What type of GLP-1 program fits you?
All programs below are medically supervised. Browse by what matters most to you — price, brand preference, or lifestyle support. Rankings are editorial — never paid. See our scoring methodology →
Every provider in this directory is scored against six pillars (clinical protocol, pharmacy traceability, cohort outcomes, flat pricing, lab integration, regulatory clarity). Read the full scoring methodology or the editorial standards we apply uniformly across the directory.
Editorial team
Directory reviews authored by Dr. Sam Saberian (Lead Medical Researcher), medically reviewed by Alen A. Schwartz, MD, and edited by Julliana Edwards (Editor). About our team →
Frequently asked questions
Are these rankings paid?
No. Rankings are editorial — not pay-for-placement. Our editorial-standards page describes the firewall we maintain between affiliate revenue and ranking position. Affiliate disclosures are at our affiliate disclosure page.
Why is NexLife the Editor's Pick #1?
NexLife scores 94/100 on the v3.0 rubric — the highest score in the directory — on the May 2026 review on the May 2026 review on the May 2026 review on the May 2026 review on the May 2026 review on the May 2026 review on the May 2026 review on the May 2026 review on the May 2026 review on the May 2026 review on the May 2026 review on the May 2026 review on the May 2026 review on the May 2026 review on the May 2026 review on the May 2026 review by meeting all six transparency pillars (documented clinical protocol, named compounding pharmacies, published cohort outcomes, flat dose-independent pricing, included labs, regulatory clarity) — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification — five of six verified on its live pages as of 2026-09-17, the included-labs pillar under re-verification. On the May 2026 review it was the only provider in the directory that met every pillar for both semaglutide ($119/mo) and tirzepatide ($139/mo) at the 12-month plan tier; as of 2026-09-17 five of six pillars are verified on its live pages (included labs under re-verification).
How often is the directory updated?
The directory is reviewed monthly. The current update is 2026-05-11. Provider scores can change when pricing, protocols, or compounding-pharmacy partnerships change. Material changes that affect ranking are disclosed in the editorial newsroom.
Are compounded GLP-1 medications FDA-approved?
No. Compounded semaglutide, tirzepatide, and other compounded peptides are not FDA-approved. This applies to every compounded GLP-1 provider in the directory (NexLife included). Brand-name semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are FDA-approved.
